Skip to main content
. 2014 Dec 23;9(3):1201–1206. doi: 10.3892/ol.2014.2823

Figure 2.

Figure 2

Immunohistochemical analysis of MAGE-D2 expression in representative patients with HCC. (A) Well-differentiated HCC with cirrhosis and (B) poorly-differentiated HCC with chronic hepatitis. MAGE-D2 was expressed at increased levels in cancerous tissues compared with adjacent non-cancerous tissue cells (original image, ×100 magnification; enlarged areas, ×400 magnification). N, non-cancerous tissue cells; T, tumor tissue cells; MAGE-D2, melanoma-associated antigen-D2; HCC, hepatocellular carcinoma.